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ABSTRACT
The use of femtosecond laser surgery improves
the precision and reproducibility of corneal
incisions and the capsular opening; it also
reduces the amount of ultrasound energy
required for lens nucleus work-up. The rate of
complications reported so far appears to be low.
There are a number of contraindications such as
a history of cornea and/or glaucoma surgery
and certain anatomical features like deep-set
eyes, kyphosis, tremor, and obesity. Visual
recovery and refractive results of both tech-
niques are excellent. Comparing laser cataract
surgery (LCS) with manual cataract surgery
(conventional phacoemulsification) based on
meta-analysis currently reveals slight differ-
ences in refractive and visual outcome. Both
methods are extremely successful and safe. LCS
is a technique still on the rise, with its full
potential not yet tapped.
Keywords: Capsulotomy; Cataract; Capsu-
lorhexis; Effective phaco time; Endothelial cell
count; Femtosecond laser; Intraocular lens; Laser
cataract surgery; Manual phacoemulsification;
Ultrasound; Prostaglandin
INTRODUCTION
In most industrialized nations, cataract surgery
is by far the most frequently performed surgical
intervention, surpassing in numbers other
common procedures from all the different sur-
gical subspecialties such as hip or knee
replacement, appendectomy, tonsillectomy,
and cholecystectomy. The advent of minimal
incisions, foldable intraocular lenses (IOL), and
the application of ultrasound energy for the
fragmentation of the lens, i.e., for phacoemul-
sification as introduced by Charles Kelman in
the 1970s, has made cataract surgery efficient
and safe. It can be argued that modern cataract
surgery—which is always refractive surgery,
striving to provide the patient with an optimal
visual acuity without requiring additional cor-
rection—is an intervention that in many cases
not only restores an organ’s function but also
can render it better than it has been for almost a
lifetime. This happens, for instance, when a
patient myopic since childhood or adolescence
becomes emmetropic after implantation of the
appropriate IOL.
New methods in medicine often face intense
and, arguably, not always fair scrutiny—even
the most beneficial inventions like smallpox
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immunization, anesthesia, and antisepsis had to
overcome initial objections. It is even more of a
challenge when an innovation has to compete
with an established method like phacoemulsi-
fication cataract surgery whose efficacy and
safety are well established. In cataract and
refractive surgery, the expectations are ever
increasing with many elderly people leading an
active lifestyle and being well informed about
the possibilities in modern ophthalmology.
Superb postoperative visual function is often
expected, sometimes even taken for granted.
For many patients, a cataract operation should
result in visual acuity of 20/20 without glasses
for distance vision. With the advent of multi-
focal and accommodating IOLs, the highest
visual comfort for near, intermediate, and dis-
tance vision is advertised. We recommend using
exactly that term—laser cataract surgery (LCS)—
to describe the new method since the laser is a
central element in the procedure and not just
an assisting device as intimated in the term
femtosecond laser-assisted cataract surgery
(FLACS) [1].
Since the introduction of the femtosecond
laser into cataract surgery by Zoltan Nagy in
2009 [2], a number of comparisons of the new
technique with conventional (manual) pha-
coemulsification have been published, based on
an ever-increasing number of cases. The assess-
ment by the pioneering surgeon Nagy that
‘‘femtolaser treatment of the crystalline lens
increases safety, efficacy, and predictability of
the surgery’’ [3] has now been tested numerous
times. Recently some major meta-analyses have
been published by Popovic et al. [4] and by Day
et al. [5] that provide valuable overviews—
though some questions still remain unanswered
and will require further research and clinical
experience.
There is probably a differing perception of
the merits of each of these two techniques,
depending on which one the individual cataract
surgeon prefers. It is the aim of this review to
provide the reader with samples of the data
from the large amount of literature on some
crucial aspects of LCS in comparison to con-
ventional phacoemulsification cataract surgery.
Some of this information stems from small
studies and/or is based on our own experience;
other results are taken from larger trials and
from meta-analyses.
This review is based on previously conducted
studies and does not involve any new studies of




Creating a precise, safe, and reproducible cap-
sulotomy is a prerequisite for success in cataract
surgery and for IOL implantation. Compared to
manual capsulorhexis [6], the laser has been
shown to create a particularly well-shaped and
reproducible capsulotomy geometry and circu-
larity [7]. Numerous studies confirmed that
these non-invasively created circular capsular
openings contribute to an improved IOL–cap-
sule overlap (Fig. 1). Capsulotomies performed
by the femtosecond laser reduce the probability
of IOL decentration and tilt [8].
Regarding the strength of the capsulotomies,
Scott et al. reported radial capsular tears in 38
eyes out of a cohort of 8684 cases. That amounts
to a rate of 0.43% [9] compared to 2.32% for
manual phacoemulsification cataract surgery
reported in the literature [10]. Roberts et al.
Fig. 1 Round, circular, centered capsulotomy in LCS with
a 360 overlap on the IOL optic (intraoperative view
through the OR microscope)
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reported an even smaller rate of anterior capsule
tears of 0.21% in a cohort of 3355 eyes [11]. In a
large study comparing 1852 eyes that under-
went LCS and 2228 eyes in the phaco group,
Abell et al. found that anterior capsule tears
occurred in 1.84% of eyes in the study group
and 0.22% of eyes in the control group
(P\0.0001). Anterior capsulotomy tags occur-
red in 1.62% of study group eyes. The authors
claimed that the higher incidence of anterior
capsule tears was not related to the learning
curve. They concluded that in general, signifi-
cant intraoperative complications that are likely
to affect refractive outcomes and patient satis-
faction were low in both groups [12].
There is evidence that the femtosecond laser
can successfully be employed when a manual
capsulorhexis turns out to be far less than per-
fect. Manual capsulorhexis, particularly when
performed by a surgeon still climbing their
learning curve, can be too small which might
lead to capsule shrinkage that in turn can cause
IOL decentration and decreased vision. In five
cases that we have described, it was possible to
enlarge a markedly smaller capsulotomy by
using the femtosecond laser with a 360 overlap
without complications. With the laser plat-
form’s 3-D spectral-domain OCT, it was possible
in all cases to identify and target the anterior
capsule. This technique has potential to be used
routinely in intended as well as unintended
cases with a smaller capsule opening [13].
Another rescue mission performed with the
femtosecond laser has been described in a
number of cases with capsular contraction syn-
drome—‘‘capsular phimosis’’—by Gerten et al.
This technique may offer advantages over the
existing treatment methods, neodymium:YAG
laser capsulotomy and manual extension of the
capsulorhexis, though tissue bridges might
remain [14].
Refractive Outcome
The earlier the capsular bag diameter stabilizes
the better for a more predictable effective lens
position, IOL power calculations, and refractive
outcomes. Measuring capsular bag shrinkage in
53 eyes that underwent LCS and in 53 fellow
eyes that underwent manual phacoemulsifica-
tion, the LCS group had significantly less cap-
sular bag shrinkage than the standard group at
1, 2, and 3 months, with a mean difference of
0.33 ± 0.25 mm at 3 months [15].
A number of studies have compared the
refractive outcome of laser and conventional
procedures—in many cases an aspect which is of
prime importance for the patient. Roberts et al.,
for instance, found no significant difference in
visual outcomes in a prospective study of 113
LCS procedures versus 105 conventional cases.
The absolute mean difference from intended
correction was 0.29 ± 0.25 D for the LCS group
and 0.31 ± 0.24 D for the standard group
(P = 0.5). More than 90% of patients in both
groups achieved 20/40 uncorrected distance
visual acuity at 3 months [16]. Mihaltz et al.
compared the ocular and internal aberrations
after femtosecond laser anterior capsulotomy
and continuous curvilinear capsulorhexis in
cataract surgery. They found no differences
between the LCS and manual groups in post-
operative sphere (-0.60 ± 1.50 vs
-0.50 ± 1.40 D), postoperative cylinder
(1.30 ± 1.01 vs 1.10 ± 1.10 D), uncorrected dis-
tance visual acuity (0.86 ± 0.15 vs 0.88 ± 0.08),
or corrected distance visual acuity (0.97 ± 0.08
vs 0.97 ± 0.06). However, they noted that the
laser group had significantly lower values of
higher-order aberrations, namely intraocular
vertical tilt (vertical deviation in the direction
of the beam of light; -0.05 ± 0.36 vs
0.27 ± 0.57), coma (variation in magnification
over the entrance pupil; -0.003 ± 0.11 vs.
0.1 ± 0.15), significantly higher Strehl ratios
(ratio of peak diffraction intensities of an aber-
rated versus perfect wavefront; 0.02 ± 0.02 vs.
0.01 ± 0.01), and modulation transfer function
values at all measured cycles per degree, com-
pared to the manual capsulorhexis group [17].
In a prospective, randomized cohort study
with the aim to analyze postoperative manifest
refraction and the deviation from the target
refraction, 100 eyes of 100 patients were treated
with femtosecond laser cataract surgery; the
fellow 100 eyes had conventional phacoemul-
sification. Six months postoperatively, 196 eyes
were included and analyzed. At 6 months, 90
eyes (92%) in the femtosecond laser group and
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70 eyes (71%) in the conventional group were
within ±0.50 D of the target refractive outcome
and 98 eyes (100%) in both groups were
within ±1.00 D. Conrad-Hengerer et al. con-
cluded that femtosecond laser cataract surgery
is a safe and precise procedure but enhances
visual outcomes only minimally. Manually
performed cataract removal in standard cases in
the hands of an experienced surgeon can obvi-
ously provide a similar level of refractive results
after 6 months. However, there was an advan-
tage in favor of the laser in the early postoper-
ative visual recovery period (until 1 week) over
conventional surgery. Furthermore, the refrac-
tive result stabilized earlier in the femtosecond
laser-assisted group [18].
Visual Acuity
A number of studies have evaluated best-cor-
rected visual acuity (BCVA) and uncorrected
distance visual acuity (UDVA) after both meth-
ods. Generally speaking, the differences in this
outcome following LCS or manual phacoemul-
sification were minimal to non-existent. Mas-
tropasqua et al. for instance found a UDVA of
0.35 logMAR in the laser group and of
0.28 logMAR in the standard phacoemulsifica-
tion group 1 month postoperatively. Six months
after surgery, the UDVA was 0.13 and
0.08 logMAR in these two respective groups [19].
Kra´nitz et al., using Snellen visual acuity, found a
UDVA of 0.59 (SD 0.23) and 0.51 (SD 0.29) in the
LCS and the standard phacoemulsification
cohorts, respectively. At 1 month, UDVA values
were 0.69 (SD 0.19) and 0.61 (SD 0.28) in
laser-operated eyes and eyes after conventional
cataract surgery, respectively; after 1 year, the
respective values were 0.63 (SD 0.23) and 0.60
(SD 0.25). They found no statistically significant
difference between arms at any time point [20].
Popovic et al. did an extensive literature
research that included 14,567 eyes from 15
randomized controlled trials and 22 observa-
tional cohort studies. Not entirely unexpected
given the high standard of the well-established
conventional procedure, no statistically signifi-
cant difference was detected between LCS and
manual phacoemulsification in uncorrected
distance visual acuity (weighted mean differ-
ence [WMD] -0.02; 95% CI -0.04 to 0.01; P 1/4
0.19), corrected distance visual acuity (WMD
-0.01; 95% CI -0.02 to 0.01; P = 0.26), and
mean absolute error (WMD -0.02; 95% CI
-0.07 to 0.04; P = 0.57). The same applied to
total surgery time. Effective phacoemulsifica-
tion time (EPT) was significantly lower in laser




In our report on the histology of corneal fem-
tosecond laser incisions we could demonstrate
the extremely precise positioning of intrastro-
mal incisions (Figs. 2 and 3), the minimal tissue
bridges left, and the absence of inflammatory
cells, pointing to a higher safety standard than
possible with a manual incision [21].
Taka´cs et al. demonstrated in a prospective,
randomized study less corneal swelling and
endothelial cell damage in patients undergoing
LCS compared to a conventional phacoemulsi-
fication technique [22]. Alio et al. compared the
stability of clear cornea incisions done by the
femtosecond laser and found that the actual
Fig. 2 Preoperative planning of the intrastromal arcuate
corneal incision in the femtosecond laser machine
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length, chord length, and surface angle for the
primary incision and the length and surface
angle for the secondary incisions were stable at
1 day and 1 month following the surgery [23].
Endothelial Cell Count and Ultrasound
Exposure
The application of ultrasound energy within the
anatomically rather confined structures of the
anterior segment is an essential step in pha-
coemulsification. It is a valuable tool, but not
without its risks. High ultrasound power and
long ultrasound time (effective phacoemulsifi-
cation time, EPT) are probably important
intraoperative factors leading to endothelial cell
loss, sometimes excessive loss, after pha-
coemulsification in healthy eyes with no pre-
vious risk factors, such as a history of
intraocular surgery, pseudoexfoliation, or cor-
neal dystrophy [24]. Ultrasound energy has also
been implicated in the pathogenesis of cystoid
macular edema [25]. With increasing experience
with femtosecond laser technology the amount
of ultrasound energy usually decreases (Fig. 4).
A study from Australia by Abell et al. com-
pared 150 patients undergoing femtosecond
laser treatment and 51 patients undergoing
conventional phacoemulsification. The study
found a mean EPT reduction in the laser group
by 83.6% with 30% of patients in this group
achieving zero EPT [26]. After femtosecond
laser-assisted cataract surgery was introduced in
our clinic, the necessity for ultrasound applica-
tion gradually declined with our growing
experience with the femtosecond laser treat-
ment. While phacoemulsification was still nee-
ded in 59% of patients (from the 200th to the
400th patient) after the introduction of LCS, in
the group comprising the 700th to the 900th
patient, only 38% required phacoemulsification
for lens fragmentation. After further climbing of
the learning curve, phacoemulsification was
required in only 9% of patients—number 1200
to number 1400. All 18 eyes that required
ultrasound energy had a grade 4 (LOCS III)
cataract and the median EPT was 0.4 s. More
than 90% of our surgeries are performed with
‘‘zero phaco’’. In grade 2 cataracts, there is cur-
rently no ultrasound application in 100% of
cases [27].
A catastrophic cell loss leading to a density of
500 or less cells per mm2 will result in corneal
decompensation which in many cases requires a
keratoplasty, either penetrating or lamellar. It is
Fig. 3 Intraoperative position check of the intrastromal
incision using 3-D SD LIVE OCT (after docking). A
change of length, depth, arc, centration method, and
position is still possible Fig. 4 Full fragmentation of the advanced cataractous lens
using a two main cut pattern (with multiple repetitions
herein) in LCS. Cavitation gas bubbles appear at the end
of the lasing
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well established that ultrasound application
during phacoemulsification can lead to
endothelial cell damage in cataract surgery due
to mechanical trauma from sonic waves and
from thermal injury [24]. While improvements
of phacoemulsification technology have made
the application less perilous for the endothe-
lium, Mencucci et al. nevertheless reported a
not insignificant endothelial cell loss between
4% and 25% [28].
There is now sufficient evidence to declare
laser cataract surgery the method less traumatic
to the corneal endothelium. In a prospective,
randomized study of 150 eyes, Conrad-Hen-
gerer et al. reported that the mean endothelial
cell loss was 7.9% ± 7.8% 1 week postopera-
tively and 8.1% ± 8.1% 3 months postopera-
tively in the LCS group and 12.1% ± 7.3% and
13.7% ± 8.4%, respectively, in the control
group (P\0.001). They found a positive corre-
lation between endothelial cell loss at the 3-
month postoperative visit (r = 0.43) and the
EPT. In the laser group 64.4% of eyes had zero
EPT. The femtosecond laser can be considered
particularly beneficial in eyes with low preop-
erative endothelial cell counts, such as in cases
of cornea guttata and Fuchs dystrophy [29]. The
differences were less pronounced in a study by
Krarup et al. with endothelial cell loss at
3 months postoperatively of 11.4% (after laser
treatment) and of 13.9% following conven-
tional phacoemulsification [30]. Schargus et al.
demonstrated that femtosecond laser treatment
allows the cataract surgeon to perform pha-
coemulsification and intraocular lens implan-
tation without the use of ophthalmic
viscosurgical device (OVD) at no additional risk
to the corneal endothelium [31].
In the aforementioned meta-analysis by
Popovic et al., the analysis of safety parameters
revealed that there were no statistically signifi-
cant differences in the incidence of overall
complications between LCS and manual catar-
act surgery; however, posterior capsular tears
were significantly more common in laser catar-
act surgery (RR 3.73). The authors add: ‘‘There
may be certain clinical scenarios, such as cases
in which a manual capsulorhexis is harder to
perform (e.g., subluxated lens), in which LCS
may have specific advantages. Furthermore,
there may be applications and modifications of
the IOL technology in the future that may favor
laser over manual cataract surgery. Because of
the continual evolution of the femtosecond
laser technology, it is likely that there will be
continued head-to-head comparisons between
these two techniques’’ [4].
Prostaglandin Release
Soon after the introduction of the femtosecond
laser into cataract surgery, first reports of intra-
operative miosis in some patients surfaced [32].
The cause of this problem—and it can be a
problem since small pupils can increase the
difficulty of the surgery and lead to higher
complication rates during lens removal [33]—
was soon identified: it is the release of pros-
taglandins by the laser treatment.
It has been well known for some time that
prostaglandins appear in the aqueous humor
following different mechanical or thermal
stimuli. The principal source for prostaglandins
in the eye is the non-pigmented epithelial layer
of the ciliary body. So we collected aqueous
humor from 113 patients who during cataract
surgery either had just undergone femtosecond
laser treatment or—in the control group of 107
eyes—before commencing conventional pha-
coemulsification. A large difference was found
between the two groups. In the femtosecond
laser group the average level of prostaglandin E2
in one part of the study was 182 pg/ml—more
than tenfold the concentration of PGE2 in the
control group, which was 17.3 pg/ml [34].
The easiest prophylaxis of an excessive
prostaglandin release might be speed. If the
patient is swiveled around on his treatment bed
from under the laser platform to the adjoining
position under the operating microscope
immediately, the prostaglandins released by
capsulotomy hardly have the time to exert their
effect on the muscularis sphincter pupillae. This
is one argument—besides, for instance, hygie-
nic considerations—in favor of performing laser
treatment and the following steps such as lens
removal and IOL in the same operating room
instead of doing the former in a separate ‘‘laser
suite’’ [35].
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There is, however, beyond the speed factor a
proven pharmacological prophylaxis: adminis-
tering non-steroidal anti-inflammatory drugs
(NSAID), one eye drop three times on the day of
surgery before initiating treatment reliably pre-
vents miosis. NSAID or steroidal pretreatment
might be advisable to decrease a possible risk of
inflammation and hence intraoperative miosis.
It is a highly effective precaution: of the last 500
eyes that received these drugs in our clinic,
none became miotic [34].
Inflammation
The prostaglandin release can trigger an alter-
ation of the blood–aqueous barrier and lead to
postoperative inflammation that can clinically
manifest as a mild iritis and with increased cells
and protein in the anterior chamber. The latter
effect causes a flare which can be quantified as
an indicator of inflammation by laser flare
photometry. Abell et al. demonstrated that
postoperative aqueous flare was significantly
greater in eyes that had undergone manual
cataract surgery at 1 day and at 4 weeks post-
operatively than in eyes after LCS [36]. Con-
rad-Hengerer et al. published similar results:
when comparing 104 eyes that underwent laser
cataract surgery with 104 fellow eyes which had
manual phacoemulsification, laser flare pho-
tometry showed higher levels in the standard
group at the first postoperative visit 2 h after
surgery compared with the laser group. In the
same study, retinal thickness was measured by
spectral-domain optical coherence tomography.
No significant differences could be detected,
indicating that LCS did not obviously influence
the incidence of postoperative macular edema
[29]. A different tendency was reported by a
group from Australia, though, with seven cases
of macular edema out of 833 eyes (0.8%) oper-
ated on with the laser vs. one eye in a group of
458 conventionally operated cases (0.1%) [37].
LCS IN CHALLENGING CASES
The safety and efficacy of LCS (Fig. 5) has been
demonstrated in a number of special cases. The
accuracy and reproducibility of the laser
capsulotomy are particularly valuable in pedi-
atric patients. A posterior capsulotomy of the
right size is crucial up to the age of 6 years to
prevent posterior capsule opacification (PCO)
and for the implantation of an IOL that is fix-
ated in the capsular bag. Because of the infant
lens capsule’s high elasticity, manual anterior
and posterior capsulorhexes are challenging to
perform and frequently lead to an oversized
capsule opening. Capsulotomy performed by
the laser has been proven safe and effective,
with tissue bridges remaining in 6 eyes out of 22
successful capsulotomies [38]. The age-depen-
dent deviation from the capsulotomy’s target
diameter which was observed in the initial
operations of children with congenital cataract
can be overcome by the Bochum formula.
Applying this formula has become crucial in
achieving a precalculated diameter and allow-
ing precise adjustment of the posterior capsu-
lotomy to the anterior capsulotomy [39].
Brunescent cataracts usually require an
increased phacoemulsification time and are at
higher risk for thermal and mechanical injury
to the cornea and corneal edema. In a study on
240 eyes, LCS was more effective than pha-
coemulsification in fragmenting the advanced
cataract in so far as requiring far less EPT. In
eyes with LOCS III grade 3 cataracts, EPT ranged
Fig. 5 Screenshot of the planning in LCS (with main
incision, two sideports, two arcuate incisions, capsulotomy,
and lens fragmentation)
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from 0.46 to 3.10 s (mean 1.38) in the phaco
group while it was zero in the laser group. In
eyes with grade 4 brunescent cataracts, EPT was
2.12 to 19.29 s (mean 6.85) in the phaco group
and 0 to 6.75 s (mean 1.35) in the laser group
[40].
A comparable situation exists with intumes-
cent cataracts which usually pose a challenge to
the surgeon since they tend to have increased
intralenticular pressure due to liquefaction of
the cortex. To release this pressure, a mini-cap-
sulotomy (Fig. 6) technique where a smaller
capsulotomy is initially performed to release the
intralenticular pressure followed by re-docking
on the laser machine and a second larger cap-
sulotomy has been developed [41], which seems
to render operating on white cataracts safe—
and probably more so than manual capsu-
lorhexis with its potential for complications
[42].
CONTRAINDICATIONS TO LCS
A number of patients will not be able to
undergo laser cataract surgery because of some
anatomical features. Deep-set eyes, a prominent
nose, and prominent eyebrows may render
contact between the globe and the laser’s
interface impossible. Heavily overweight
patients may not fit onto the treatment bed and
lowering the interface will in cases of obesity
not result in coupling to the cornea’s surface.
Skeletal anomalies like a pronounced kyphosis
might prevent patients from lying down prop-
erly under the treatment unit. A tremor and
restless legs syndrome are also contraindica-
tions. LCS should not be performed in eyes with
previous glaucoma or cornea surgery. Corneal
scars are mentioned as contraindications;
depending on their extent, experienced sur-
geons might consider this an obstacle that can
be overcome.
DISCUSSION
Femtosecond laser treatment shows great pro-
mise in increasing the accuracy and precision of
the cuts compared to the manual procedure.
Favorable refractive and functional outcomes
and good safety profiles have been reported.
The Cochrane analysis comparing LCS with
standard phacoemulsification cataract surgery
concluded that in the evaluated studies there
was a small difference in postoperative refrac-
tion prediction error (mean absolute error) in
favor of laser-assisted surgery but the confi-
dence intervals for this estimate included a
clinically insignificant effect. The general con-
clusion of the analysis was that evidence from
the 16 randomized controlled trials (RCTs)
included in the Cochrane review could not
determine the equivalence or superiority of
laser-assisted cataract surgery compared to
standard manual phacoemulsification for the
chosen outcomes because of the low to very low
certainty of the evidence available from these
studies [5].
LCS provides new options in the treatment
of advanced pathologies. Furthermore, there are
evolving techniques to reduce the likelihood of
postoperative capsule opacification as recently
described by Gregory Kramer, Liliana Werner,
and Nick Mamalis [43] that certainly can be
employed in laser-assisted operations as well as
in manual cataract surgery. Preventing this
most common complication after cataract sur-
gery to a certain degree is probably also possible
Fig. 6 Mini-capsulotomy on intraoperative laser system
screen view demonstrating its centration, position, and size
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by employing the laser to perform a primary
posterior capsulotomy (Fig. 7) [44].
The two major meta-analyses published very
recently give proof that both techniques, LCS
and manual phacoemulsification, are highly
effective and safe with differences in some
parameters minor or non-existent. Besides the
publication by Popovic et al. that was men-
tioned earlier, the Cochrane review by Day et al.
found little evidence of any important differ-
ence in postoperative visual acuity between
laser-assisted and standard phacoemulsification
arms. There was a small advantage for laser-as-
sisted cataract surgery at 6 months in corrected
distance visual acuity (CDVA). The mean dif-
ference (MD) was -0.03 logMAR and was con-
sidered clinically insignificant. None of the
analyzed trials were powered to investigate for
differences in complication rates [5].
With growing experience, LCS has—like
manual phacoemulsification—become a proce-
dure that can be used in most of the patients.
Patients representing challenging cases like
those with Marfan syndrome [45], intumescent
cataract as well as pediatric cases do not have to
be turned away although these interventions
require a high degree of surgical skills.
There are a number of contraindications,
however, and some patients are without doubt
better served by manual cataract surgery.
A field where LCS lags behind conventional
phacoemulsification is the economic side of this
frequent intervention. Abell et al., using a
computer-based econometric modeling, con-
cluded in 2014 that laser cataract surgery at the
time of publication is not cost-effective com-
pared to phacoemulsification [46]. This
approach has, however, some weaknesses and
does not take into account, for instance, costs
that arise from complications like corneal
decompensation and the expenses for glasses
etc. to correct remaining refractive errors after
cataract surgery. Like with any new technology,
it is likely that the price of laser cataract surgery
will decrease over time.
LCS has a large clinical potential that has not
yet been fully tapped with new applications like
intraoperative biomorphometry on the horizon.
CONCLUSION
According to a number of studies femtosecond
laser surgery has the potential to improve the
precision and reproducibility of corneal inci-
sions and the capsular opening. It has been
documented that LCS reduces the amount of
ultrasound energy required for lens removal.
The reported rate of complications is low and
there are limited contraindications. Visual
recovery and refractive results are promising.
There are, however, a couple of challenges fac-
ing wider acceptance of the femtosecond laser
in cataract surgery. The economic aspect is of
importance. The higher costs are a barrier to
wider acceptance by surgeons and clinical cen-
ters. However, to increase acceptance the next
generation of the lasers systems needs to be
smaller, more mobile, and less dependent on a
narrowly defined room temperature than the
current ones. LCS is still a young technology in
progress and surgeons can offer their patients
two safe and efficient techniques in operating
cataracts: LCS and—not ‘‘versus’’, not ‘‘or’’—
phacoemulsification.
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